Assured Pharmacy, Inc. Receives Gross Proceeds of $300,000 from Sale of Convertible Debentures and Warrants
FRISCO, Texas, Dec. 8, 2010 /PRNewswire-FirstCall/ -- Assured Pharmacy, Inc. (Pink Sheets: APHY) (the "Company"), a growing chain of specialty pharmacies that provides advanced prescription services to a diverse array of medical professionals and their patients, announced today that it sold in a private placement to an accredited investor a 12.5% senior convertible debenture for an aggregate principal amount of $300,000 (before deducting expenses and fees related to the private placement). The debentures are convertible into shares of the Company's common stock at an initial conversion price of $0.008 per share, subject to adjustment. As part of the private placement, the investor received a warrant to purchase 45,000,000 shares of the Company's common stock. The warrant is exercisable for a period of three years from the date of issuance at an initial exercise price of $0.0096, subject to adjustment. The investor may exercise the warrant on a cashless basis if the shares of common stock underlying the Warrant are not then registered pursuant to an effective registration statement. The funds received from the investor will be directed to the continued development of the Company's business plan and general working capital purposes.
This financing is supporting the Company's ongoing business expansion and investment into solidifying its supply chain of prescription medications. "We are very pleased to have the support of this investment as we enter the next phase of our business model," stated Mr. Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. "As we lay the foundation for expanding our pharmacy footprint into new markets, improving our financial position with suppliers is critical and this financing furthers that requirement."
The securities sold by the Company in the private placement were not registered